[Myoneural conduction blockade by choline esters in the presence of cholinesterase inhibitors and restoration of conduction by cholinesterase reactivators].
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002801:Cholinesterase Reactivators / Q000494:pharmacology*; D003964:Diaphragm / Q000294:innervation; D066298:In Vitro Techniques; D008916:Miotics / Q000494:pharmacology; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D063065:Organophosphonates / Q000494:pharmacology; D009943:Organophosphorus Compounds / Q000494:pharmacology; D009946:Organothiophosphorus Compounds / Q000494:pharmacology; D010091:Oximes / Q000494:pharmacology; D010791:Phrenic Nerve / Q000187:drug effects; D011726:Pyridinium Compounds / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects*
D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D008916:Miotics; D003473:Neuromuscular Nondepolarizing Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D009946:Organothiophosphorus Compounds; D010091:Oximes; D011726:Pyridinium Compounds; D000644:Quaternary Ammonium Compounds; D011807:Quinolizines; D009388:Neostigmine; D000109:Acetylcholine
Blakada mionevral'nogo provedeniia éfirami kholina v prisutstvii ingibitorov kholinésteraz i vosstanovlenie provedeniia reaktivatsieĭ kholinésteraz.